Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Ann Abiola Ogbenna
Seema Meloni
Seth Inzaule
Raph L Hamers
Kim Sigaloff
Akin Osibogun
Titilope Adenike Adeyemo
Prosper Okonkwo
Jay Osi Samuels
Phyllis J Kanki
Tobias F Rinke de Wit
Alani Sulaimon Akanmu

January 2020

IntroductionHIV is a highly diverse virus with significant genetic variability which may confer biol...

Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and

Immunological Responses To Cart

September 2016

Background. To analyze the time trends of the viral subtype distributions according to gender, risk ...

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

Venner, Colin M.
Nankya, Immaculate
Kyeyune, Fred
Demers, Korey
Kwok, Cynthia
Chen, Pai-Lien
Rwambuya, Sandra
Munjoma, Marshall
Chipato, Tsungai
Byamugisha, Josaphat
Van Der Pol, Barbara
Mugyenyi, Peter
Salata, Robert A.
Morrison, Charles S.
Arts, Eric J.

November 2016

AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

Scherrer, A.U.
Ledergerber, B.
von Wyl, V.
Böni, J.
Yerly, S.
Klimkait, T.
Bürgisser, P.
Rauch, A.
Hirschel, B.
Cavassini, M.
Elzi, L.
Vernazza, P.L.
Bernasconi, E.
Held, L.
Günthard, H.F.

January 2011

BACKGROUND: Antiretroviral compounds have been predominantly studied in human immunodeficiency virus...

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared

To Subtype B

October 2016

(See the Editorial Commentary by Gatell, on pages 1153–5.) Background. Antiretroviral compounds have...

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B

Scherrer, Alexandra U
Ledergerber, Bruno
von Wyl, Viktor
Böni, Jürg
Yerly, Sabine
Klimkait, Thomas
Bürgisser, Philippe
Rauch, Andri
Hirschel, Bernard
Cavassini, Matthias
Elzi, Luigia
Vernazza, Pietro L
Bernasconi, Enos
Held, Leonhard
Günthard, Huldrych F
Swiss HIV Cohort Study,

January 2011

Antiretroviral compounds have been predominantly studied in human immunodeficiency virus type 1 (HIV...

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration

G. Touloumi
N. Pantazis
M.L. Chaix
H.C. Bucher
R. Zangerle
A.M. Kran
R. Thiebaut
B. Masquelier
C. Kucherer
A. D&#8217
L. Meyer
K. Porter
for CASCADE Collaboration in EuroCoord

July 2013

BACKGROUND: We aimed to compare rates of virologic response and CD4 changes after combination antire...

Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype

Sergei L. Kosakovsky Pond
Davey M. Smith

January 2015

Currently, 24 active antiretroviral agents are available for use in the United States. These agents ...

Antiretroviral Therapy for HIV: Do Subtypes Matter?

Jose ́ M. Gatell

October 2016

(See the article by Scherrer et al, on pages 1143–52.) About 2 years ago, in a past issue of Clinica...

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis

May, MT
Gill, MJ
Wittkop, L
Klein, M
Sabin, C
Harrigan, PR
Dunn, D
Vehreschild, JJ
Rubio, R
Mocroft, A
Cavassini, M
Reiss, P
Monforte, AD
Zangerle, R
Ingle, SM
Hill, T
Jose, S
Sterne, JAC
Boulle, A
Stephan, C
Miro, JM
Cavassini, M
Chene, G-V
Costagliola, D
Dabis, F
Monforte, AD
Del Amo, J
Van Sighem, A
Vehreschild, J
Gill, J
Guest, J
Haerry, DH-U
Hogg, R
Justice, A
Mocroft, A
Obel, N
Crane, H
Smith, C
Reiss, P
Saag, M
Sterling, T
Teira, R
Williams, M
Zangerle, R
Sterne, J
May, M
Ingle, S
Trickey, A
Ainsworth, J
Anderson, J
Babiker, A
Chadwick, D
Delpech, V
Dunn, D
Fisher, M
Gazzard, B
Gilson, R
Hay, P
Gompels, M
Hill, T
Johnson, M
Jose, S
Kegg, S
Leen, C
Mackie, N
Nelson, M
Orkin, C
Palfreeman, A
Phillips, A
Pillay, D
Post, F
Sabin, C
Sachikonye, M
Schwenk, A
Walsh, J
Thornton, A
Huntington, S
Glabay, A
Orkin, C
Garrett, N
Lynch, J
Hand, J
De Souza, C
Fisher, M
Perry, N
Tilbury, S
Youssef, E
Churchill, D
Gazzard, B
Nelson, M
Waxman, M
Asboe, D
Mandalia, S
Anderson, J
Munshi, S
Awosika, D
Post, F
Korat, H
Taylor, C
Gleisner, Z
Ibrahim, F
Campbell, L
Babiker, A
Dunn, D
Glabay, A
Chadwick, D
Baillie, K
Cope, E
Gibney, M
Gibson, J
Gilson, R
Brima, N
Williams, I
Ainsworth, J
Schwenk, A
Miller, S
Wood, C
Johnson, M
Youle, M
Lampe, F
Smith, C
Chaloner, C
Hill, T
Huntington, S
Jose, S
Phillips, A
Sabin, C
Thornton, A
Walsh, J
Mackie, N
Winston, A
Weber, J
Ramzan, F
Carder, M
Leen, C
Wilson, A
Morris, S
Gompels, M
Allan, S
Palfreeman, A
Moore, A
Fox, L
Bojanowski, J
Lewszuk, A
Kegg, S
Main, P
Mitchell, D
Hunter, D
Sachikonye, M
Hay, P
Dhillon, M
Martin, F
Douglas, S
Russell-Sharp, S

October 2015

Objectives: To estimate prognosis by viral subtype in HIV-1-infected individuals from start of antir...

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.

Giota Touloumi
Nikos Pantazis
Marie-Laure Chaix
Heiner C Bucher
Robert Zangerle
Anne-Marte Bakken Kran
Rodolphe Thiebaut
Bernard Masquelier
Claudia Kucherer
Antonella d'Arminio Monforte
Laurence Meyer
Kholoud Porter

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

Kantor, R
Katzenstein, DA
Efron, B
Carvalho, AP
Wynhoven, B
Cane, P
Clarke, J
Sirivichayakul, S
Soares, MA
Snoeck, J
Pillay, C
Rudich, H
Rodrigues, R
Holguin, A
Ariyoshi, K
Bouzas, MB
Cahn, P
Sugiura, W
Soriano, V
Brigido, LF
Grossman, Z
Morris, L
Vandamme, AM
Tanuri, A
Phanuphak, P
Weber, JN
Pillay, D
Harrigan, PR
Camacho, R
Schapiro, JM
Shafer, RW

March 2005

Background: The genetic differences among HIV-1 subtypes may be critical to clinical management and ...

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

Ogbenna, Ann Abiola
Meloni, Seema
Inzaule, Seth
Hamers, Raph L.
Sigaloff, Kim
Osibogun, Akin
Adeyemo, Titilope Adenike
Okonkwo, Prosper
Samuels, Jay Osi
Kanki, Phyllis J.
de Wit, Tobias F. Rinke
Akanmu, Alani Sulaimon

August 2020

Introduction HIV is a highly diverse virus with significant genetic variability which may confer bio...

HIV-1 Genetic Variability and Clinical Implications

SANTORO, MARIA
PERNO, CARLO FEDERICO

January 2013

Despite advances in antiretroviral therapy that have revolutionized HIV disease management, effectiv...

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

Poon, A
Ndashimye, E
Avino, M
Gibson, R
Kityo, C
Kyeyune, F
Nankya, I
Quiñones-Mateu, M
Arts, E
The Ugandan Drug Resistance Study Team
Hamers, R

January 2019

BACKGROUND: Our understanding of HIV-1 and antiretroviral treatment (ART) is strongly biased towards...

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Ann Abiola Ogbenna
Seema Meloni
Seth Inzaule
Raph L Hamers
Kim Sigaloff
Akin Osibogun
Titilope Adenike Adeyemo
Prosper Okonkwo
Jay Osi Samuels
Phyllis J Kanki
Tobias F Rinke de Wit
Alani Sulaimon Akanmu

January 2020

IntroductionHIV is a highly diverse virus with significant genetic variability which may confer biol...

Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and

Immunological Responses To Cart

September 2016

Background. To analyze the time trends of the viral subtype distributions according to gender, risk ...

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

Venner, Colin M.
Nankya, Immaculate
Kyeyune, Fred
Demers, Korey
Kwok, Cynthia
Chen, Pai-Lien
Rwambuya, Sandra
Munjoma, Marshall
Chipato, Tsungai
Byamugisha, Josaphat
Van Der Pol, Barbara
Mugyenyi, Peter
Salata, Robert A.
Morrison, Charles S.
Arts, Eric J.

November 2016

AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

Scherrer, A.U.
Ledergerber, B.
von Wyl, V.
Böni, J.
Yerly, S.
Klimkait, T.
Bürgisser, P.
Rauch, A.
Hirschel, B.
Cavassini, M.
Elzi, L.
Vernazza, P.L.
Bernasconi, E.
Held, L.
Günthard, H.F.

January 2011

BACKGROUND: Antiretroviral compounds have been predominantly studied in human immunodeficiency virus...

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared

To Subtype B

October 2016

(See the Editorial Commentary by Gatell, on pages 1153–5.) Background. Antiretroviral compounds have...

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B

Scherrer, Alexandra U
Ledergerber, Bruno
von Wyl, Viktor
Böni, Jürg
Yerly, Sabine
Klimkait, Thomas
Bürgisser, Philippe
Rauch, Andri
Hirschel, Bernard
Cavassini, Matthias
Elzi, Luigia
Vernazza, Pietro L
Bernasconi, Enos
Held, Leonhard
Günthard, Huldrych F
Swiss HIV Cohort Study,

January 2011

Antiretroviral compounds have been predominantly studied in human immunodeficiency virus type 1 (HIV...

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration

G. Touloumi
N. Pantazis
M.L. Chaix
H.C. Bucher
R. Zangerle
A.M. Kran
R. Thiebaut
B. Masquelier
C. Kucherer
A. D&#8217
L. Meyer
K. Porter
for CASCADE Collaboration in EuroCoord

July 2013

BACKGROUND: We aimed to compare rates of virologic response and CD4 changes after combination antire...

Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype

Sergei L. Kosakovsky Pond
Davey M. Smith

January 2015

Currently, 24 active antiretroviral agents are available for use in the United States. These agents ...

Antiretroviral Therapy for HIV: Do Subtypes Matter?

Jose ́ M. Gatell

October 2016

(See the article by Scherrer et al, on pages 1143–52.) About 2 years ago, in a past issue of Clinica...

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis

May, MT
Gill, MJ
Wittkop, L
Klein, M
Sabin, C
Harrigan, PR
Dunn, D
Vehreschild, JJ
Rubio, R
Mocroft, A
Cavassini, M
Reiss, P
Monforte, AD
Zangerle, R
Ingle, SM
Hill, T
Jose, S
Sterne, JAC
Boulle, A
Stephan, C
Miro, JM
Cavassini, M
Chene, G-V
Costagliola, D
Dabis, F
Monforte, AD
Del Amo, J
Van Sighem, A
Vehreschild, J
Gill, J
Guest, J
Haerry, DH-U
Hogg, R
Justice, A
Mocroft, A
Obel, N
Crane, H
Smith, C
Reiss, P
Saag, M
Sterling, T
Teira, R
Williams, M
Zangerle, R
Sterne, J
May, M
Ingle, S
Trickey, A
Ainsworth, J
Anderson, J
Babiker, A
Chadwick, D
Delpech, V
Dunn, D
Fisher, M
Gazzard, B
Gilson, R
Hay, P
Gompels, M
Hill, T
Johnson, M
Jose, S
Kegg, S
Leen, C
Mackie, N
Nelson, M
Orkin, C
Palfreeman, A
Phillips, A
Pillay, D
Post, F
Sabin, C
Sachikonye, M
Schwenk, A
Walsh, J
Thornton, A
Huntington, S
Glabay, A
Orkin, C
Garrett, N
Lynch, J
Hand, J
De Souza, C
Fisher, M
Perry, N
Tilbury, S
Youssef, E
Churchill, D
Gazzard, B
Nelson, M
Waxman, M
Asboe, D
Mandalia, S
Anderson, J
Munshi, S
Awosika, D
Post, F
Korat, H
Taylor, C
Gleisner, Z
Ibrahim, F
Campbell, L
Babiker, A
Dunn, D
Glabay, A
Chadwick, D
Baillie, K
Cope, E
Gibney, M
Gibson, J
Gilson, R
Brima, N
Williams, I
Ainsworth, J
Schwenk, A
Miller, S
Wood, C
Johnson, M
Youle, M
Lampe, F
Smith, C
Chaloner, C
Hill, T
Huntington, S
Jose, S
Phillips, A
Sabin, C
Thornton, A
Walsh, J
Mackie, N
Winston, A
Weber, J
Ramzan, F
Carder, M
Leen, C
Wilson, A
Morris, S
Gompels, M
Allan, S
Palfreeman, A
Moore, A
Fox, L
Bojanowski, J
Lewszuk, A
Kegg, S
Main, P
Mitchell, D
Hunter, D
Sachikonye, M
Hay, P
Dhillon, M
Martin, F
Douglas, S
Russell-Sharp, S

October 2015

Objectives: To estimate prognosis by viral subtype in HIV-1-infected individuals from start of antir...

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.

Giota Touloumi
Nikos Pantazis
Marie-Laure Chaix
Heiner C Bucher
Robert Zangerle
Anne-Marte Bakken Kran
Rodolphe Thiebaut
Bernard Masquelier
Claudia Kucherer
Antonella d'Arminio Monforte
Laurence Meyer
Kholoud Porter

We aimed to compare rates of virologic response and CD4 changes after combination antiretroviral (cA...

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

Kantor, R
Katzenstein, DA
Efron, B
Carvalho, AP
Wynhoven, B
Cane, P
Clarke, J
Sirivichayakul, S
Soares, MA
Snoeck, J
Pillay, C
Rudich, H
Rodrigues, R
Holguin, A
Ariyoshi, K
Bouzas, MB
Cahn, P
Sugiura, W
Soriano, V
Brigido, LF
Grossman, Z
Morris, L
Vandamme, AM
Tanuri, A
Phanuphak, P
Weber, JN
Pillay, D
Harrigan, PR
Camacho, R
Schapiro, JM
Shafer, RW

March 2005

Background: The genetic differences among HIV-1 subtypes may be critical to clinical management and ...

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

Ogbenna, Ann Abiola
Meloni, Seema
Inzaule, Seth
Hamers, Raph L.
Sigaloff, Kim
Osibogun, Akin
Adeyemo, Titilope Adenike
Okonkwo, Prosper
Samuels, Jay Osi
Kanki, Phyllis J.
de Wit, Tobias F. Rinke
Akanmu, Alani Sulaimon

August 2020

Introduction HIV is a highly diverse virus with significant genetic variability which may confer bio...

HIV-1 Genetic Variability and Clinical Implications

SANTORO, MARIA
PERNO, CARLO FEDERICO

January 2013

Despite advances in antiretroviral therapy that have revolutionized HIV disease management, effectiv...

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

Poon, A
Ndashimye, E
Avino, M
Gibson, R
Kityo, C
Kyeyune, F
Nankya, I
Quiñones-Mateu, M
Arts, E
The Ugandan Drug Resistance Study Team
Hamers, R

January 2019

BACKGROUND: Our understanding of HIV-1 and antiretroviral treatment (ART) is strongly biased towards...

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Ann Abiola Ogbenna
Seema Meloni
Seth Inzaule
Raph L Hamers
Kim Sigaloff
Akin Osibogun
Titilope Adenike Adeyemo
Prosper Okonkwo
Jay Osi Samuels
Phyllis J Kanki
Tobias F Rinke de Wit
Alani Sulaimon Akanmu

January 2020

IntroductionHIV is a highly diverse virus with significant genetic variability which may confer biol...

Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and

Immunological Responses To Cart

September 2016

Background. To analyze the time trends of the viral subtype distributions according to gender, risk ...

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

Venner, Colin M.
Nankya, Immaculate
Kyeyune, Fred
Demers, Korey
Kwok, Cynthia
Chen, Pai-Lien
Rwambuya, Sandra
Munjoma, Marshall
Chipato, Tsungai
Byamugisha, Josaphat
Van Der Pol, Barbara
Mugyenyi, Peter
Salata, Robert A.
Morrison, Charles S.
Arts, Eric J.

November 2016

AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B

Abstract

Extracted data

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B

Abstract

Extracted data

Topics

Related items

Topics

Related items